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ABSTRACT 
Objectives: Genome-wide association studies in patients with endometriosis revealed ten significant single nucleo-
tide polymorphisms (SNPs) in the Caucasian population, which include rs12700667 near NFE2L3, rs12037376 in WNT4, 
rs7521902 near WNT4, rs13394619 in GREB1, rs10859871 near VEZT, rs1537377 near CDKN2B-AS1, rs4141819 near ETAA1, 
rs7739264 near ID4, rs1519761 near RND3 and rs6542095 near IL1A. 
Material and methods: We replicated ten polymorphisms among infertile women with endometriosis (n = 315) and healthy 
fertile women (n = 406) in the Polish Caucasian population. Genotyping was conducted either by high-resolution melting 
curve analysis or by a pre-designed TaqMan probe. 
Results: For all infertile women with endometriosis, the p values of the Cochran-Armitage trend test for the rs12700667 SNP 
was ptrend = 0.038 and the odds ratio (OR) for the risk allele frequency (RAF) of rs12700667 was 1.304 (95% CI = 1.009–1.685; 
p = 0.042). In patients with endometriosis with severity stages III/IV, ptrend for rs12700667 SNP was 0.036 and OR for the 
RAF was 1.394 (95% CI = 1.010–1.923; p = 0.043). In infertile women with endometriosis with severity stages III/IV for 
rs4141819 SNP, we observed ptrend = 0.026 and for RAF the OR = 1.350 (95% CI = 1.032–1.766; p = 0.029). 
Conclusions: Our results demonstrate association of RAF of rs12700667 and rs4141819 SNPs with infertility in Polish 
women with advanced endometriosis. 
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INTRODUCTION 
Endometriosis is a complex gynaecological health pro-
blem in women, which is characterized by the aberrant pre-
sence of endometrial cells outside the uterus [1]. This benign 
disease is usually limited to the pelvis and is characterized 
by peritoneal inflammation, neovascularization, fibrosis, and 
ovarian cysts [1]. The morbidity for endometriosis ranges 
from 5–10% and is accompanied by subfertility in women 
at reproductive age [2, 3]. Despite the extensive conducted 
studies, the aetiology of endometriosis is still unclear. The 
presence of endometrial tissue and cells in the peritoneal 
cavity has been explained by the standard theory of retro-
grade menstruation along the fallopian tubes [4]. Although 
retrograde menstruation is observed in 90% of women, 
merely 10–20% of women suffer from endometriosis, which 
suggests the involvement of different genetic and environ-
mental components in etiopathogenesis [5, 6]. Recently, the 
genetic and epigenetic background of endometriosis has 
been demonstrated [5]. The aetiology of endometriosis 
may be related to genetic factors, which increases oestro-
gen activity, the production of prostaglandins, cytokines, 
and metalloproteinases, as well as enhances of oncogenic 
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pathways [5]. To date, five genome-wide association stu-
dies (GWAS) have been conducted on four independent 
groups, encompassing women with endometriosis [7–13]. 
These GWAS analyses have revealed ten genome-wide si-
gnificant loci in Caucasians, presented in Table 1 [7–13]. 
Despite finding several genome-wide significant loci linked 
to endometriosis, there is still a need for confirmation in 
different populations. 
We aimed to assess the rs12700667, rs12037376, 
rs7521902, rs13394619, rs10859871, rs1537377, rs4141819, 
rs7739264, rs1519761 and rs6542095 SNPs genome-wide 
significant loci (Tab. 1) as possible infertility risk in Polish 
women with endometriosis.
MATERIAL AND METHODS
A case-control study 
A case-control study design was used in 315 patients 
with endometriosis and 406 matched controls (Tab. 2). Pe-
ripheral blood samples were randomly obtained between 
November 2014 and December 2017 from infertile women 
with endometriosis and control women of similar ages from 
the Gynaecologic and Obstetrical University Hospital, Divi-
sion of Reproduction at Poznan University of Medical Scien-
ces, Poland (Tab. 1). After informed consent was obtained, 
approximately 7 mL venous blood was drawn and collected 
into the Vacutainer System with EDTA (Sarstedt, Germany) 
and stored at –20°C until DNA isolation was performed. 
The patients with infertility and endometriosis un-
derwent laparoscopy and had a histologically confirmed 
diagnosis at the Gynaecologic and Obstetrical University 
Hospital, Division of Reproduction at Poznan University 
of Medical Sciences, Poland. Patients with endometriosis 
were divided into two subgroups according to the revised 
American Society for Reproductive Medicine (rASRM) clas-
sification system [14]; n = 142 patients had minimal or mild 
endometriosis (stages I–II), n = 166 had moderate or severe 
endometriosis (stages III–IV), and n = 7 patients had an un-
defined stage of endometriosis (Tab. 2). The control group 
was comprised of healthy women (n = 406), without history 
of infertility, who had a caesarean section performed (Tab. 2). 
 The inclusion and exclusion criteria for the infertile 
women with endometriosis and the women without dise-
ase were previously described [15]. The inclusion criteria 
for infertile women diagnosed with endometriosis were 
as follows: regular menses, no anatomical changes in the 
reproductive tract, no hormonal treatments, and a minimum 
of one year of infertility with a current desire for conception. 
The exclusion criteria were as follows: mechanical distortion 
of the endometrial cavity by fibroids, bilateral tubal occlu-
sion, male factor infertility, adenomyosis, polycystic ovary 
syndrome (PCOS) and benign or malignant gynaecological 
diseases. The inclusion criteria for fertile control women 
were as follows: performed caesarean section, regular men-
ses, no anatomical changes in the reproductive tract, no 
hormonal treatments, and at least one child born no more 
than one year before the study (Tab. 2). The exclusion criteria 
were as follows: signs of past or present inflammation, pelvic 
abnormalities, endometriosis, adenomyosis, PCOS or any 
other benign or malignant gynaecological diseases, which 
was confirmed during surgical exploration. Both patients 
with endometriosis and healthy controls were all Caucasians 
of Polish ancestry (Tab. 2). 
Ethical approval 
All procedures performed in this study which involved 
human participants were in accordance with the ethical 
standards of the ethics committee of Poznan University of 
Medical Sciences and with the 1964 Helsinki declaration and 
its ethical standards. Informed consent was obtained from 
all individual participants included in the study. 
Table 1. Characteristics of SNPs genotyped in the data set
SNP Locus Location (bp)a Allelesb SNP location Genec
rs12700667 7p15.2 25901639 A / G intergenic NPVF / NFE2L3 
rs12037376 1p36.12 22462111 A / G intronic WNT4
rs7521902 1p36.12 22490724 A / C intergenic WNT4 / ZBTB40 
rs13394619 2p25.1 11727507 A / G intronic (function: splice-3) GREB1
rs10859871 12q22 95711876 A / C intergenic VEZT / METAP2 
rs1537377 9p21.3 22169700 C / T intergenic CDKN2B / DMRTA1 
rs4141819 2p14 67864675 C / T intergenic ETAA1 / C1D
rs7739264 6p22.3 19785588 C / T intergenic RNF144B / ID4 
rs1519761 2q23.3 151633204 A / G intergenic RND3 / RBM43 
rs6542095 2q13 113529183 C / T intergenic CKAP2L / IL1A 
a — NCBI build 37 / hg19; b — underline denotes the minor allele; c — genes separated by forward slash indicate nearest protein coding genes upstream / downstream 
of the SNP
306
Ginekologia Polska 2018, vol. 89, no. 6
www. journals.viamedica.pl/ginekologia_polska
Genotyping of rs12700667, rs12037376, 
rs7521902, rs13394619, rs10859871, rs1537377, 
rs4141819, rs7739264, rs1519761  
and rs6542095 SNPs 
Genomic DNA was isolated from peripheral blood leu-
kocytes by salt extraction. The SNPs evaluated in this study 
were selected based on GWAS and meta-analyses stud-
ies [8, 9, 11–13]. Genotyping of rs12700667, rs12037376, 
rs7521902, rs13394619, rs10859871, rs1537377, rs4141819, 
rs7739264, and rs1519761 variants was carried out by high 
resolution melting curve analysis (HRM) on the LightCycler 
96 system (Roche Diagnostics, Mannheim, Germany) with 
the use of 5x HOT FIREPol EvaGreen HRM Mix (Solis BioDyne, 
Tartu, Estonia). The PCR programme consisted of an initial 
step at 95°C for 15 minutes to activate HOT FIREPol DNA 
polymerase, followed by 50 amplification cycles of denatur-
ation at 95°C for 10 seconds, primer-dependent annealing 
(Tab. 3) for 10 seconds, and elongation at 72°C for 15 sec-
onds. Amplified DNA fragments were then subjected to HRM 
with 0.1°C increments in temperatures ranging from 65 to 
95°C (Tab. 3). The final concentrations of reagents in HRM 
reactions were as follows: 1x HOT FIREPol EvaGreen HRM 
Mix, 0.2 pmol/µL of each primer and 2 ng/µL DNA template. 
The HRM reactions were performed in a 10 μL volume. Ge-
notyping of rs6542095 was carried out on the LightCycler 
480 system (Roche Diagnostics, Mannheim, Germany) using 
pre-designed TaqMan SNP, according to the manufacturer’s 
instructions provided by Applied Biosystems (Applied Bio-
systems, Foster City, CA, USA) (Tab. 3).
Data analysis
Hardy-Weinberg equilibrium (HWE) was assessed by 
Pearson’s goodness-of-fit Chi-square (χ2) statistic. The SNPs 
were studied for associations with endometriosis using the 
Table 2. Characteristics of the populations of infertile women with 
endometriosis 
Characteristics 
and fertile healthy 
women
Infertile women with 
endometriosis
Fertile healthy 
women
Numbers 315 406
Age (years) 31 (21–36)a 31 (19–38)a
Parity NA 1 (1–4)a
Duration of infertility 
(years) 3 (1–7)
a NA
rASRM (stage)b
Stage I and II (n = 142
Stage III and IV (n = 166)
Undefined (n = 7)
NA
a — median (range); b — revised American Society for Reproductive Medicine 
(rASRM) [14]; NA — not applicable
Table 3. Primers and HRM conditions for replication genotyping
rs no. Alleles Primers for PCR amplification(5’–3’)
PCR product 
length (bp)
Annealing 
temp. (°C)
Melt. temp. 
range (°C)
rs12700667 A / G
F: GAGAGTGAAAATGTGACAAAAGTGA
90 55 74–89
R: AAGCGCCACACCATATACATC
rs12037376 A / G
F: GAGACCACAGGCTTCCATA
78 55 78–93
R: TTCAGGAGTAAGGGGTGCT
rs7521902 A / C
F: GCTCTGTCTTCGAGGCACTT
104 53 80–95
R: TCCCAATTACATGATCCTCTCC
rs13394619 A / G
F: CCCCTTGTCACTTCTCTGTC
119 55 75–90
R: TACCATTTGGGTAGCACCA
rs10859871 A / C
F: CAAGTGGGCAATTTATTTCTCTG
144 58 74–89
R: TGCAATAGGATTCTCACATTAACCT
rs1537377 C / T
F: CAGCTCTACTCTTGGATTTGG
110 55 72–87
R: ATGCATAACAGTCTATAAGTAGG
rs4141819 C / T
F: CCTCAGGTGAAAGTTCATGC
85 55 75–90
R: TGAGGAAAGTGGCTAGAGGA
rs7739264 C / T
F: GAGGCCACTCACTACAATGC
137 53 75–90
R: CCTCTTGGACAGATTTTCCTG
rs1519761 A / G
F: CAAAAATATGTTGTATATGAG
91 53 65–80
R: TAATCCATGTTTTCCTAC
Genotyping of rs6542095 was carried out on the LightCycler 480 system (Roche Diagnostics, Mannheim, Germany) using pre-designed TaqMan SNP Genotyping Assay 
according to the manufacturer’s instructions provided by Applied Biosystems (Applied Biosystems, Foster City, CA)
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Cochran-Armitage trend test. Differences in the risk allele 
frequencies (RAF) between the cases and controls were 
calculated using χ2 analysis. The odds ratio (OR) and 95% 
confidence intervals (95% CI) were also calculated. The 
statistical analyses were conducted with Statistica version 
10 (2011, Stat Soft, Inc., Tulsa, USA).
RESULTS
 The comparison of rs12700667, rs12037376, 
rs7521902, rs13394619 rs10859871, rs1537377, 
rs4141819, rs7739264, rs1519761 and rs6542095 
genotypes and allele frequencies between  
all infertile women with endometriosis  
and fertile healthy women 
There was no divergence from the HWE in the frequ-
ency of genotypes between all infertile women with en-
dometriosis and the fertile women groups (Tab. 4). The 
prevalence of the genotype and allele frequencies, OR 
and 95% CI calculated for the ten SNPs are presented in 
Table 4. The statistical significance of the p values of the 
Cochran-Armitage trend test (ptrend = 0.038) was found for 
the rs12700667 SNP and the OR for RAF was 1.304 (95% 
CI = 1.009–1.685; p = 0.042). However, none of the SNPs, 
rs12037376, rs7521902, rs13394619, rs10859871, rs1537377, 
rs4141819, rs7739264, rs1519761 or rs6542095 displayed 
a significant association with all infertile women with endo-
metriosis in the additive inheritance model (Tab. 4). 
The comparison of rs12700667, rs12037376, 
rs7521902, rs13394619, rs10859871, rs1537377, 
rs4141819, rs7739264, rs1519761 and rs6542095 
genotypes and allele frequencies between 
infertile women with endometriosis in stages  
III and IV and fertile healthy women 
We found divergence from the HWE in the frequency 
of genotypes in the subgroup with endometriosis with se-
verity stage I/II for rs1519761 but no divergence was ob-
served from the HWE for other subgroups of women with 
Table 4. Association between GWAS-identified polymorphisms and the risk of endometriosis
SNP Genotypes RAFa ptrend 
ORallelic (95%CI)
b;
p valuec HW
d
rs12700667 AA / AG / GG A — major
Controls 229 / 154 / 19 0.76 0.560
Cases 201 / 101 / 10 0.81 0.038 1,304 (1,009–1,685); 0.042 0.821
Cases stage I and II 91 / 42 / 7 0.80 0.178 1,255 (0.898–1,754); 0.183 0.761
Cases stage III and IV 108 / 55 / 3 0.82 0.036 1,394 (1,010–1,923); 0.043 0.403
rs12037376 GG / AG / AA A — minor
Controls 285 / 112 / 8 0.16 0.732
Cases 211 / 89 / 11 0.18 0.302 1,157 (0.876–1,530); 0.304 0.914
Cases stage I and II 97 / 39 / 5 0.17 0.533 1,121 (0.781–1,608); 0.537 0.909
Cases stage III and IV 109 / 48 / 6 0.18 0.281 1,202 (0.857–1,685); 0.286 0.969
rs7521902 CC / AC / AA A — minor
Controls 218 / 155 / 24 0.26 0.876
Cases 159 / 133 / 18 0.27 0.462 1,091 (0.860–1,384); 0.474 0.354
Cases stage I and II 71 / 63 / 5 0.26 0.814 1,037 (0.760–1,415); 0.820 0.133
Cases stage III and IV 85 / 68 / 12 0.28 0.417 1,125 (0.843–1,502); 0.422 0.950
rs13394619 GG / AG / AA A — minor
Controls 126 / 184 / 89 0.45 0.379
Cases 96 / 154 / 59 0.44 0.618 0.947 (0.767–1,170); 0.612 0.981
Cases stage I and II 44 / 75 / 22 0.42 0.365 0.879 (0.668–1,157); 0.358 0.562
Cases stage III and IV 52 / 74 / 37 0.45 0.992 1,001 (0.773–1,297); 0.991 0.561
rs10859871 AA / AC / CC C — minor
Controls 197 / 166 / 42 0.31 0.728
Cases 140 / 151 / 23 0.31 0.835 1,024 (0.818–1,282); 0.837 0.117
Cases stage I and II 69 / 65 / 8 0.29 0.459 0.894 (0.664–1,204); 0.460 0.344
Cases stage III and IV 67 / 85 / 13 0.34 0.357 1,135 (0.864–1,491); 0.362 0.142
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endometriosis with severity stages I/II and III/IV (Tab. 4). The 
prevalence of the genotype and allele frequencies, OR, and 
95% CI calculated for the ten SNPs for both fertile healthy 
women and women with endometriosis stages I/II and III/IV 
are presented in Table 4. In patients with endometriosis with 
severity stages III/IV, for the rs12700667 SNP, we found sta-
tistically significant p values of the Cochran-Armitage trend 
test (ptrend = 0.036) and OR for the RAF of 1.394 (95% CI = 
= 1.010–1.923; p = 0.043). In infertile women with endome-
triosis stages III/IV, for rs4141819 SNP, we observed statisti-
cally significant p values of the Cochran-Armitage trend test 
( ptrend = 0.026) and OR for the RAF of 1.350 (95% CI = 1.032–
–1.766; p = 0.029). However, we did not find any association 
between rs12700667 and rs4141819 SNPs in women with 
endometriosis severity stages I/II. Moreover, rs12037376, 
rs7521902, rs13394619, rs10859871, rs1537377, rs7739264, 
rs1519761 and rs6542095 failed to display a significant asso-
ciation with infertile women with endometriosis in stages I/II 
and III/IV in additive inheritance models (Tab. 4). 
DISCUSSION 
Large twin studies revealed approximately 50% heri-
tability of endometriosis [16]. Numerous investigations on 
various candidate genes have been carried out to study the 
genetic background of endometriosis; however, some stu-
dies did not replicate these results [16, 17]. Previous efforts 
to study the genetic background of endometriosis suggest 
that it is a highly complex field [5, 16, 17]. 
 Previous replication studies and meta-analysis stu-
dies conducted on GWAS in European ancestry cohorts 
found ten genome-wide significant single nucleoti-
de polymorphisms (SNPs) associated with advanced 
endometriosis in Caucasians [7–13,18]. These include 
rs12700667 on 7p15.2 near NFE2L3 (erythroid-derived 
2-like 3), rs12037376 in WNT4 (wingless-type MMTV inte-
gration site family, member 4), rs7521902 on 1p36.12 near 
WNT4, rs13394619 on 2p25.1 in GREB1 (growth regulation 
by oestrogen in breast cancer 1), rs10859871 on 12q22 near 
VEZT (vezatin, adherens junctions transmembrane protein), 
Table 4 (cont.). Association between GWAS-identified polymorphisms and the risk of endometriosis
SNP Genotypes RAFa ptrend 
ORallelic (95%CI)
b;
p valuec HW
d
rs1537377 TT / CT / CC C — minor
Controls 144 / 198 / 58 0.39 0.749
Cases 101 / 165 / 45 0.41 0.491 1,075 (0.869–1,332); 0.505 0.234
Cases stage I and II 47 / 78 / 16 0.39 0.941 0.990 (0.750–1,307); 0.943 0.155
Cases stage III and IV 50 / 84 / 29 0.44 0.173 1,194 (0.920–1,551); 0.182 0.828
rs4141819 TT / CT / CC C — minor
Controls 195 / 171 / 38 0.31 0.998
Cases 124 / 151 / 31 0.35 0.0856 1,212 (0.9693–1,517) 0.0913 0.311
Cases stage I and II 64 / 64 / 13 0.32 0.672 1,065 (0.795–1,425); 0.674 0.870
Cases stage III and IV 60 / 87 / 18 0.37 0.026 1,350 (1,032–1,766); 0.029 0.261
rs7739264 TT / CT / CC C — minor
Controls 124 / 191 / 89 0.46 0.636
Cases 92 / 149 / 70 0.46 0.770 1,033 (0.837–1,273); 0.765 0.808
Cases stage I and II 42 / 62 / 37 0.48 0.473 1,108 (0.845–1,454); 0.458 0.366
Cases stage III and IV 47 / 84 / 32 0.45 0.935 0.989 (0.764–1,281); 0.934 0.881
rs1519761 AA / AG / GG G — minor
Controls 125 / 209 / 65 0.42 0.357
Cases 104 / 162 / 44 0.40 0.394 0.915 (0.739–1,132); 0.413 0.319
Cases stage I and II 42 / 84 / 14 0.40 0.441 0.903 (0.684–1,191); 0.469 0.013
Cases stage III and IV 59 / 76 / 28 0.40 0.531 0.921 (0.709–1,197); 0.539 0.918
rs6542095 TT / CT / CC C – minor
Controls 201 / 178 / 25 0.28 0.212
Cases 168 / 126 / 21 0.27 0.501 0.925 (0.732–1,169); 0.514 0.922
Cases stage I and II 76 / 53 / 13 0.28 0.985 0.980 (0.725–1,325); 0.897 0.702
Cases stage III and IV 87 / 71 / 8 0.26 0.467 0.903 (0.677–1,206); 0.490 0.394
RAF — risk allele frequency
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rs1537377 on 9p21.3 near CDKN2B-AS1 (cyclin-dependent 
kinase inhibitor 2B antisense RNA), rs4141819 on 2p14 near 
ETAA1 (ewing tumour-associated antigen 1), rs7739264 on 
6p22.3 near ID4 (inhibitor of DNA binding 4, dominant ne-
gative helix-loop-helix protein), rs1519761 on 2q23.3 near 
RND3 (Rho family GTPase 3 gene) and rs6542095 on 
2q13 near IL1A (interleukin 1A) (Tab. 1) [7–13,18]. 
In our study we found association of the rs12700667 po-
lymorphism with infertility in Polish women with advanced 
endometriosis. The GWAS study conducted by Painter et 
al. 2011 demonstrated rs12700667 SNP association with 
advanced endometriosis in Australia and the UK cohort and 
was replicated in independent cohort from the United States 
[10]. The rs12700667 SNP is located ~290.2 kb upstream of 
the nuclear factor NFE2L3. Recently, in a Chinese population, 
it was reported that rs12700667 significantly increased the 
risk of ovarian endometriosis [19]. 
We also found contribution of the rs4141819 polymor-
phism to infertility in Polish women with advanced endome-
triosis. The GWAS study carried out by Nyholt et al. 2012 re-
vealed in European and Japanese ancestry rs4141819 SNP as 
risk factor for advanced endometriosis [9]. The rs4141819 SNP 
is situated ~227.0 kb downstream of the ETAA1 gene that 
encodes a tumour-specific cell surface antigen in the Ewing 
family of tumours [20]. The rs4141819 SNP is also located 
in the intronic region of a long non-coding RNA (lncRNA), 
AC007422.1, which has an unknown biological function. The 
association of rs12700667 and rs4141819 SNPs should be 
repeated in other independent Polish cohorts to assess the 
possible diagnostic value of these polymorphism in the de-
velopment of infertility in Polish women with endometriosis. 
However, we did not observe an association between 
rs12037376, rs7521902, rs13394619, rs10859871, rs1537377, 
rs7739264, rs1519761 and rs6542095 SNPs with infertility in 
Polish women with advanced endometriosis. 
The GWAS study conducted in endometriotic women 
with European ancestry found association with the introno-
nic rs12037376 SNP of WNT4 and rs7521902 SNP situated 
~21.3 kb downstream of WNT4 [8, 9]. WNT4 is considered to 
be associated with the development of the female genital 
tract and steroidogenesis [21]. 
Both rs13394619 and rs10859871 are endometriosis 
susceptible SNPs, that have been identified by GWAS me-
ta-analysis in Japanese and European populations [9]. The 
rs13394619 SNP is situated in the intron region between 
exon 9 and exon 10 in the GREB1 gene, which is involved 
in hormone-dependent breast cancer cell growth [22]. 
Elevated expression of GREB1 has been suggested to be 
involved in oestrogen-dependent growth in peritoneal en-
dometriosis [23]. The rs10859871 SNP is located ~15.3 kb 
downstream of the VEZT gene, which is a putative tumour 
suppressor gene encoding an adherens junction transmem-
brane protein [24]. The rs10859871 SNP was replicated in 
Italian Caucasian women with endometriosis [25]. Recently, 
Holdsworth-Carson et al. (2016) reported the association 
of the rs10859871 SNP with increased VEZT expression in 
the secretory phase of the menstrual cycle in endometrial 
glands of women with endometriosis [26]. 
In the Nyholt et al., (2012) study of European ancestry 
they found an association of rs1537377 and rs7739264 SNPs 
with endometriosis, excluding cases with minimal or unk-
nown severity [9]. The rs1537377 SNP is located ~48 kb 
upstream of the CDKN2B-AS1 gene. This gene, which is at the 
9p21.3. locus, was first demonstrated in GWAS of endome-
triosis in a Japanese population [11]. CDKN2B-AS1 regulates 
CDKN2A, CDKN2B and ARF expression, which are known as 
tumour suppressor genes [27–29]. CDKN2A inactivation has 
been observed in endometriosis and endometrial cancer 
via loss of heterozygosity and promoter hypermethylation 
[30, 31]. The rs7739264 SNP is situated ~52.0 kb upstream 
of the ID4 gene and in the intronic region of lncRNA, RP1–
–167F1.2, with unknown function. Changes in ID4 expression 
is involved in ovarian and breast carcinogenesis [32, 33]. 
The GWAS study carried out by Albertsen et al. (2013) has 
identified rs1519761 SNP to be associated with endometrio-
sis in a European cohort [8]. The rs1519761 is located in the 
intergenic region ~289 kb downstream of the RND3 gene 
(OMIM *602924). 
The Sapkota et al. (2015) study on a population of Eu-
ropean ancestry revealed an association of rs6542095 SNP 
with a genome-wide significance in patients with moderate-
-to-severe endometriosis [13]. The rs6542095 SNP is situated 
~2.3 kb downstream of the IL1A gene. This SNP may regulate 
the expression of other genes, which could support the 
evidence for a relationship between the pathogenesis of 
endometriosis and inflammatory responses [34]. 
CONCLUSIONS 
In our studies we replicated the rs12700667 and 
rs4141819 association of RAF with infertility in Polish wo-
men with advanced endometriosis. However, we did not 
replicate rs12037376, rs7521902, rs13394619, rs10859871, 
rs1537377, rs7739264, rs1519761 and rs6542095 SNPs in 
infertile women, neither with all stages of endometriosis 
nor advanced endometriosis. The frequency of genetic po-
lymorphisms varies according to ethnic groups, which may 
have effect on the sample size to get statistical power of 
study. Our study attributes the small population and lack of 
sufficient power for replication. Therefore, this study should 
be replicated in other independent cohorts. 
310
Ginekologia Polska 2018, vol. 89, no. 6
www. journals.viamedica.pl/ginekologia_polska
Acknowledgements
This work was supported by grant no. 502-01-01124182-
-07474 from Poznań University of Medical Sciences. The 
technical assistance of Ms. Justyna Dąbrowska is gratefully 
acknowledged. 
REFERENCES 
1. Wilczyński M, Wiecka-Płusa M, Antosiak B, et al. Rectovaginal endome-
triosis--analysis of 160 cases. Ginekol Pol. 2015; 86(12): 896–901, indexed 
in Pubmed: 26995938.
2. Bulun SE. Endometriosis. N Engl J Med. 2009; 360(3): 268–279, doi: 
10.1056/NEJMra0804690, indexed in Pubmed: 19144942.
3. Luca A, Nemescu D, Butnaru M, et al. Ovarian stimulation outcome in 
infertile women with endometriosis undergoing IVF. Ginekol Pol. 2016; 
87(1): 37–41, doi: 10.17772/gp/60073, indexed in Pubmed: 27306467.
4. Davis AC, Goldberg JM. Extrapelvic Endometriosis. Semin Reprod Med. 
2017; 35(1): 98–101, doi: 10.1055/s-0036-1597122, indexed in Pubmed: 
27992931.
5. Borghese B, Zondervan KT, Abrao MS, et al. Recent insights on the gene-
tics and epigenetics of endometriosis. Clin Genet. 2017; 91(2): 254–264, 
doi: 10.1111/cge.12897, indexed in Pubmed: 27753067.
6. Jurkiewicz-Przondziono J, Lemm M, Kwiatkowska-Pamuła A, et al. 
Influence of diet on the risk of developing endometriosis. Ginekol Pol. 
2017; 88(2): 96–102, doi: 10.5603/GP.a2017.0017, indexed in Pubmed: 
28326519.
7. Adachi S, Tajima A, Quan J, et al. Meta-analysis of genome-wide associa-
tion scans for genetic susceptibility to endometriosis in Japanese popu-
lation. J Hum Genet. 2010; 55(12): 816–821, doi: 10.1038/jhg.2010.118, 
indexed in Pubmed: 20844546.
8. Albertsen HM, Chettier R, Farrington P, et al. Genome-wide association 
study link novel loci to endometriosis. PLoS One. 2013; 8(3): e58257, 
doi: 10.1371/journal.pone.0058257, indexed in Pubmed: 23472165.
9. Nyholt DR, Low SK, Anderson CA, et al. Genome-wide association 
meta-analysis identifies new endometriosis risk loci. Nat Genet. 2012; 
44(12): 1355–1359, doi: 10.1038/ng.2445, indexed in Pubmed: 23104006.
10. Painter JN, Anderson CA, Nyholt DR, et al. Genome-wide association stu-
dy identifies a locus at 7p15.2 associated with endometriosis. Nat Genet. 
2011; 43(1): 51–54, doi: 10.1038/ng.731, indexed in Pubmed: 21151130.
11. Uno S, Zembutsu H, Hirasawa A, et al. A genome-wide association 
study identifies genetic variants in the CDKN2BAS locus associated 
with endometriosis in Japanese. Nat Genet. 2010; 42(8): 707–710, doi: 
10.1038/ng.612, indexed in Pubmed: 20601957.
12. Rahmioglu N, Nyholt DR, Morris AP, et al. Genetic variants underlying 
risk of endometriosis: insights from meta-analysis of eight genome-wide 
association and replication datasets. Hum Reprod Update. 2014; 20(5): 
702–716, doi: 10.1093/humupd/dmu015, indexed in Pubmed: 24676469.
13. Sapkota Y, Fassbender A, Bowdler L, et al. Independent Replication and 
Meta-Analysis for Endometriosis Risk Loci. Twin Res Hum Genet. 2015; 
18(5): 518–525, doi: 10.1017/thg.2015.61, indexed in Pubmed: 26337243.
14. Canis M, Donnez JG, Guzick DS, et al. Revised American Society for Re-
productive Medicine classification of endometriosis: 1996. Fertil Steril. 
1997; 67(5): 817–821, doi: 10.1016/s0015-0282(97)81391-x., indexed in 
Pubmed: 9130884.
15. Szczepańska M, Wirstlein P, Skrzypczak J, et al. Polymorphic variants of 
CYP17 and CYP19A and risk of infertility in endometriosis. Acta Obstet 
Gynecol Scand. 2013; 92(10): 1188–1193, doi: 10.1111/aogs.12210, 
indexed in Pubmed: 23809139.
16. Saha R, Pettersson HJ, Svedberg P, et al. Heritability of endometriosis. Fer-
til Steril. 2015; 104(4): 947–952, doi: 10.1016/j.fertnstert.2015.06.035, 
indexed in Pubmed: 26209831.
17. Rahmioglu N, Montgomery GW, Zondervan KT. Genetics of endometrio-
sis. Womens Health (Lond). 2015; 11(5): 577–586, doi: 10.2217/whe.15.41, 
indexed in Pubmed: 26441051.
18. Sapkota Y, Low SK, Attia J, et al. Association between endometriosis and 
the interleukin 1A (IL1A) locus. Hum Reprod. 2015; 30(1): 239–248, doi: 
10.1093/humrep/deu267, indexed in Pubmed: 25336714.
19. Li Y, Hao Na, Wang YX, et al. Association of Endometriosis-Associated Genetic 
Polymorphisms From Genome-Wide Association Studies With Ovarian En-
dometriosis in a Chinese Population. Reprod Sci. 2016 [Epub ahead of print], 
doi: 10.1177/1933719116650753, indexed in Pubmed: 27233752.
20. Borowski A, Dirksen U, Lixin L, et al. Structure and function of ETAA16: 
a novel cell surface antigen in Ewing’s tumours. Cancer Immunol Immu-
nother. 2006; 55(4): 363–374, doi: 10.1007/s00262-005-0017-6, indexed 
in Pubmed: 16003559.
21. Vainio S, Heikkilä M, Kispert A, et al. Female development in mammals 
is regulated by Wnt-4 signalling. Nature. 1999; 397(6718): 405–409, doi: 
10.1038/17068, indexed in Pubmed: 9989404.
22. Rae JM, Johnson MD, Scheys JO, et al. GREB 1 is a critical regulator of 
hormone dependent breast cancer growth. Breast Cancer Res Treat. 
2005; 92(2): 141–149, doi: 10.1007/s10549-005-1483-4, indexed in 
Pubmed: 15986123.
23. Pellegrini C, Gori I, Achtari C, et al. The expression of estrogen receptors 
as well as GREB1, c-MYC, and cyclin D1, estrogen-regulated genes im-
plicated in proliferation, is increased in peritoneal endometriosis. Fertil 
Steril. 2012; 98(5): 1200–1208, doi: 10.1016/j.fertnstert.2012.06.056, 
indexed in Pubmed: 22884659.
24. Miao R, Guo X, Zhi Q, et al. VEZT, a novel putative tumor suppressor, 
suppresses the growth and tumorigenicity of gastric cancer. PLoS 
One. 2013; 8(9): e74409, doi: 10.1371/journal.pone.0074409, indexed 
in Pubmed: 24069310.
25. Pagliardini L, Gentilini D, Sanchez AM, et al. Replication and meta-ana-
lysis of previous genome-wide association studies confirm vezatin as 
the locus with the strongest evidence for association with endometrio-
sis. Hum Reprod. 2015; 30(4): 987–993, doi: 10.1093/humrep/dev022, 
indexed in Pubmed: 25678572.
26. Holdsworth-Carson SJ, Fung JN, Luong HTT, et al. Endometrial vezatin 
and its association with endometriosis risk. Hum Reprod. 2016; 31(5): 
999–1013, doi: 10.1093/humrep/dew047, indexed in Pubmed: 27005890.
27. Jarinova O, Stewart AFR, Roberts R, et al. Functional analysis of the chro-
mosome 9p21.3 coronary artery disease risk locus. Arterioscler Thromb 
Vasc Biol. 2009; 29(10): 1671–1677, doi: 10.1161/ATVBAHA.109.189522, 
indexed in Pubmed: 19592466.
28. Liu Y, Sanoff HK, Cho H, et al. INK4/ARF transcript expression is asso-
ciated with chromosome 9p21 variants linked to atherosclerosis. PLoS 
One. 2009; 4(4): e5027, doi: 10.1371/journal.pone.0005027, indexed in 
Pubmed: 19343170.
29. Pasmant E, Laurendeau I, Héron D, et al. Characterization of a germ-line 
deletion, including the entire INK4/ARF locus, in a melanoma-neural sys-
tem tumor family: identification of ANRIL, an antisense noncoding RNA 
whose expression coclusters with ARF. Cancer Res. 2007; 67(8): 3963–3969, 
doi: 10.1158/0008-5472.CAN-06-2004, indexed in Pubmed: 17440112.
30. Goumenou AG, Arvanitis DA, Matalliotakis IM, et al. Loss of heterozygo-
sity in adenomyosis on hMSH2, hMLH1, p16Ink4 and GALT loci. Int J Mol 
Med. 2000; 6(6): 667–671, indexed in Pubmed: 11078826.
31. Martini M, Ciccarone M, Garganese G, et al. Possible involvement of 
hMLH1, p16(INK4a) and PTEN in the malignant transformation of en-
dometriosis. Int J Cancer. 2002; 102(4): 398–406, doi: 10.1002/ijc.10715, 
indexed in Pubmed: 12402310.
32. Ren Y, Cheung HW, von Maltzhan G, et al. Targeted tumor-penetrating 
siRNA nanocomplexes for credentialing the ovarian cancer oncogene 
ID4. Sci Transl Med. 2012; 4(147): 147ra112, doi: 10.1126/scitransl-
med.3003778, indexed in Pubmed: 22896676.
33. Verschuur-Maes AHJ, de Bruin PC, van Diest PJ. Epigenetic progression 
of columnar cell lesions of the breast to invasive breast cancer. Breast 
Cancer Res Treat. 2012; 136(3): 705–715, doi: 10.1007/s10549-012-2301-
4, indexed in Pubmed: 23104224.
34. Miller JE, Ahn SH, Monsanto SP, et al. Implications of immune dysfunction 
on endometriosis associated infertility. Oncotarget. 2017; 8(4): 7138–
7147, doi: 10.18632/oncotarget.12577, indexed in Pubmed: 27740937.
